Literature DB >> 28828658

Multi-Surface Antigen Staining of Larger Extracellular Vesicles.

Veronika Lukacs-Kornek1, Henrike Julich-Haertel1, Sabine Katharina Urban1, Miroslaw Kornek2.   

Abstract

Larger extracellular vesicles, microparticles (MPs) or microvesicles (MVs), especially their acquisition and characterization by flow cytometry (FACS), is increasingly in focus of clinical/translational research efforts. Several laboratories have shown that MPs/MVs might be suitable for the diagnosis and predicting prognosis in various diseases including cancer. However, FACS staining of larger extracellular vesicles (EVs) can be difficult and results potentially in false positive and inconsistent data interpretation. Despite that FACS equipment is well maintained and the operators have ample experience, a reliable and for larger EVs optimized staining protocol is missing. Here, we aim to close that gap and provide a working multi-antibody staining protocol for larger EVs isolated from human serum samples. We describe in detail the needed steps as currently done in our laboratory. Staining is demonstrated exemplarily for multi-antibody mix including CD147 , a potential cancer marker if applied in combination with other MP/MV surface markers.

Entities:  

Keywords:  Antibody; Flow cytometry; Larger extracellular vesicles; Microparticles; Microvesicles; Surface antigen staining

Mesh:

Substances:

Year:  2017        PMID: 28828658     DOI: 10.1007/978-1-4939-7253-1_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  The Neuroprotective Lipocalin Apolipoprotein D Stably Interacts with Specific Subtypes of Detergent-Resistant Membrane Domains in a Basigin-Independent Manner.

Authors:  Miriam Corraliza-Gomez; Manuela Del Caño-Espinel; Diego Sanchez; Maria D Ganfornina
Journal:  Mol Neurobiol       Date:  2022-04-22       Impact factor: 5.682

Review 2.  Microvesicles in Cancer: Small Size, Large Potential.

Authors:  Kerstin Menck; Suganja Sivaloganathan; Annalen Bleckmann; Claudia Binder
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.